Project Duration: October 2021 – September 2026
Funding: The Screen4Care EU-IMI project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034427. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Website: The Project | Screen4Care
General objectives:
The aim of Screen4Care is to shorten the time it takes rare disease patients to get a diagnosis and treatment. It will do this through two pillars:
- The project will drive the genetic screening of newborn babies using genetic testing and advanced genomic technologies.
- The project will design new artificial intelligence (AI) algorithms to identify rare disease patients early on in their disease via electronic health records. The project will also develop a repository of AI ‘symptom checkers’ to help patients who are already waiting for a diagnosis.
In addition, Screen4Care aims to establish a digital infrastructure and ecosystem to engage patients, parents of newborns and caregivers as equal decision-makers in the diagnosis process. The ecosystem will provide an open innovation platform, which allows for continuous data collection and information exchange, aiding the development of next-generation diagnostics and enabling physicians, patients and relatives to make informed decisions at an earlier stage.